Pharma Marketing Blog represents the opinions of
John Mack
Publisher of
Pharma Marketing News.
We accept advertising relevant to the interests of our members.
For more information, see:
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
| Return to All Pharma Marketing Blog Topics |
If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.
Listed in reverse chronologic al order:
- Exciting News: FDA approves new use for CRESTOR
- FDA Won't be Previewing TV DTC Ads!
- Did Pfizer Run a Chantix "Bookend" Ad During 60 Minutes?
- FDA DTC Payola Out, You Pay In!
- Mevacor - STRIKE THREE! Yer Outta Here!
- The "One-Click Rule": Rant or No Rant?
- The Natrecor Waterboard Tortured Tchotchke
- What the US FDA Could Learn from China's FDA
- Pfizer Facebook a la Sermo?
- Regulating DTC for BTC
- DTC Here to Stay; Pet Turtles Too!
- Web 2.0 Pharma Marketing Tricks for Dummies
- An Innovative System for Communicating Drug Risks to Patients
- FDA Considers Color Code for Food Labels, But Not for Drug Labels
- FDA at a Mall Near You: The Manchurian Connection
- FDA's Chang and Eng: Benefit vs. Risk
- FDA: Zimulti Non-Acomplia!
- Is Big Pharma Shifty?
- Avandia: Enough Blame to Go Around
- Temple vs. Nissen: Blood Rematch
- Advice to GSK on Handling the Avandia Avalanche: Don't Do What Merck Did
- Device DTC: Imagine How Far It Will Go!
- Acomplia Not for the Gun Totting Bikini Crowd
- von Eschenbach & Gonzales: Two Birds in the Same Bush
- FDA Advisor Rule Loophole?
- Back to School for Takeda, Rozerem, and Abe Lincoln!
- Drug Safety - A Mere Asterisk to the FDA
- Nice Try, Daiichi!
- PDUFA Payola!
- Brave New Pharma?
- If FDA were as Powerful as FTC
- What Was Blogworthy in 2006? A Review
- DTC Set to Surpass DTPhysician
- Where's DDMAC's Head At?
- Lame-Duck Senate Roasts Eschenbach Turkey!
- Pay Per DTC Ad View Update
- What's In Store from Congress?
- CommonHealth's Selective Release of DTC Study Data
- Lunesta, Google, and "bAdWords"
- Apres IOM, le Deluge!
- IOM Report Calls for DTC Moratorium
- Advertisers Don't Know How DTC Works. Say wha?
- Pay-(FDA)-Per-(Pre)View of DTC
- WLF: A No-Risk Ad is a Good Ad
- Accountability: Imported vs. Domestic
- Fear & Loathing in Bethesda
- FDA Paralyzed: Who Will Protect Us?
- FDA Gets a "C" from the Public
- Celsius 3014: Ketek, Drug Safety, & Bioterrorism
- Spinning Bad News about FDA & Drug Safety
- FDA Coming to a Mall Near You?
- Merck Misled FDA According to NJ Jury
- FDA Backs Down on Coupon Study
- FDA, Coupons, and Sleep Aid DTC Ads
- AstraZeneca's Risky Proposition
- Plan B FDAgate
- FDA DTC Hearings Day 2
- FDA DTC Hearings: Snippets from Day 1
- DTC Regulation: Trick or Treat?
- FDA May Follow PhRMA's Lead on DTC
- Bloggers Worry Pharma More Than FDA
- HELP WANTED: Director of Drug Safety
- WLF Watches FDA Watching Drug Ads
- Proposal for a Drug Risk Advisory System
- FDA Drug Watch Site Guidelines
- FDA Advisory Panels: Elephants in the Room
- Does the FDA Need to be Overhauled?
- How the FDA Can Fix DTC